High Tower Advisors, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $9,300 - $17,170	-100 Reduced 33.33%	200 $2,000
Q1 2020 May 21, 2020	SELL	$82.38 - $131.64 $24,714 - $39,491	-300 Reduced 50.0%	300 $6,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $22,959 - $40,674	-300 Reduced 33.33%	600 $10,000
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $50,967 - $109,837	700 Added 350.0%	900 $2,000
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $10,667 - $15,168	100 Added 100.0%	200 $1,000
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $7,173 - $15,369	-100 Reduced 50.0%	100 $1,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $7,145 - $9,430	200	200 $2,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.